The mixed neutron-photon beam of FiR 1 reactor is used for boron-neutron capture therapy (BNCT) in Finland. A beam model has been defined for patient treatment planning and dosimetric calculations. The neutron beam model has been validated with an activation foil measurements. The photon beam model has not been thoroughly validated against measurements, due to the fact that the beam photon dose rate is low, at most only 2% of the total weighted patient dose at FiR 1. However, improvement of the photon dose detection accuracy is worthwhile, since the beam photon dose is of concern in the beam dosimetry. In this study, we have performed ionization chamber measurements with multiple build-up caps of different thickness to adjust the calculated...
Photon quality correction factors (kQy) for ionization chamber photon dosimetry in an epithermal neu...
The purpose of this publication was to present and evaluate the methods for reference dosimetry in t...
The clinical trials of glioma patients with boron neutron capture therapy (BNCT) started in May 1999...
The mixed neutron-photon beam of FiR 1 reactor is used for boron-neutron capture therapy (BNCT) in F...
Accurate radiation dosimetry is of paramount importance in order to ensure safe delivery of radiothe...
In radiotherapy, uncertainty regarding the the absorbed dose in a patient has to be on a level such ...
A Boron Neutron Capture Therapy (BNCT) treatment facility with an epithermal neutron beam has been s...
Cancer is one of the main disease to threat for human health. Besides surgery and medical treatment ...
The Finnish BNCT facility with a new epithermal beam is close to complete.1 The neutron spectrum of ...
In this paper, the accuracy of dose planning calculations for boron neutron capture therapy (BNCT) o...
Magnesium-walled argon gas flow ionization chamber (Mg(Ar)) is used for photon dose measurements in ...
For the development and clinical implementation of the particular type of radiotherapy BNCT, it is o...
In the Finnish BNCT (boron neutron capture therapy) project the final configuration of the FiR 1 bea...
Two clinical phase I/II protocols (P01, P03) on boron neutron capture therapy (BNCT) for the treatme...
The beam was successfully characterized in air and in phantom using various radiation dosimeter:,. T...
Photon quality correction factors (kQy) for ionization chamber photon dosimetry in an epithermal neu...
The purpose of this publication was to present and evaluate the methods for reference dosimetry in t...
The clinical trials of glioma patients with boron neutron capture therapy (BNCT) started in May 1999...
The mixed neutron-photon beam of FiR 1 reactor is used for boron-neutron capture therapy (BNCT) in F...
Accurate radiation dosimetry is of paramount importance in order to ensure safe delivery of radiothe...
In radiotherapy, uncertainty regarding the the absorbed dose in a patient has to be on a level such ...
A Boron Neutron Capture Therapy (BNCT) treatment facility with an epithermal neutron beam has been s...
Cancer is one of the main disease to threat for human health. Besides surgery and medical treatment ...
The Finnish BNCT facility with a new epithermal beam is close to complete.1 The neutron spectrum of ...
In this paper, the accuracy of dose planning calculations for boron neutron capture therapy (BNCT) o...
Magnesium-walled argon gas flow ionization chamber (Mg(Ar)) is used for photon dose measurements in ...
For the development and clinical implementation of the particular type of radiotherapy BNCT, it is o...
In the Finnish BNCT (boron neutron capture therapy) project the final configuration of the FiR 1 bea...
Two clinical phase I/II protocols (P01, P03) on boron neutron capture therapy (BNCT) for the treatme...
The beam was successfully characterized in air and in phantom using various radiation dosimeter:,. T...
Photon quality correction factors (kQy) for ionization chamber photon dosimetry in an epithermal neu...
The purpose of this publication was to present and evaluate the methods for reference dosimetry in t...
The clinical trials of glioma patients with boron neutron capture therapy (BNCT) started in May 1999...